How to handle vaccine hesitancy at work
Alan Price, CEO at BrightHR, discusses how employers and HR departments can handle vaccine hesitancy in the workplace.
All UK adults could be offered COVID vaccine by May
According to recent reports, all UK adults could have their first dose of the COVID vaccine by May, 2021 - opening up the potential of a real summer.
UK Government invests £20 million into electric vehicle chargepoints
The UK Transport Secretary, Grant Shapps, has announced that the government will be investing £20 million into electric vehicle chargepoints.
High infection numbers can undo our vaccination programmes
The vaccine roll out gives hope of a return to some form of normality, but current high COVID-19 infection numbers put the success of vaccination programmes at risk. Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences explain why.
UK Government allocates £50 million to support students during pandemic
The UK Government has allocated an additional £50 million to support students facing financial pressures from the pandemic.
Scientists find dark matter halo around ancient galaxy
MIT astrophysicists looked 163,000 light years from Earth, to find that a tiny, ancient galaxy has a dark matter halo - meaning that the very first galaxies in the universe were more immense than anyone imagined.
South African COVID-19 variant found in UK
Additional testing has been deployed across the UK after a COVID-19 variant originally identified in South Africa has been found .
Medicaid expansion improves pregnancy outcomes for low-income women
A professor describes severe maternal morbidity in low-income women as a public health crisis - now, Medicaid expansion seems to be improving pregnancy outcomes.
UK purchases additional 40 million doses of Valneva vaccine
The UK government has announced that it has secured early access to a further 40 million doses of the Valneva COVID-19 vaccine.
Scientists find new truths about how forests impact air quality
Researchers are looking at how forests impact air quality, based on the classification of temperate trees and what that means for how the forest really works.
Third of Americans say they are unlikely to get COVID-19 vaccine
A new study by the University of California, Davis has found that a third of Americans are either unlikely or hesitant to get a COVID-19 vaccine when it becomes available.
Johnson & Johnson vaccine has 66% efficiency in one dose
New clinical trial data shows that the Johnson & Johnson vaccine is able to give 66% protection against COVID in one dose - with an 85% efficiency at the standard double-dose.
Treating bovine tuberculosis (bTB) with artificial intelligence
Craig Rhodes, EMEA Industry Lead for Artificial Intelligence Healthcare and Life Science at NVIDIA, explores how bovine tuberculosis (bTB) can be monitored and treated more effectively and efficiently using Artificial Intelligence (AI).
Domestic abuse services receive £40m to support victims
Specialist support services for victims of rape and domestic abuse will receive an extra £40 million funding boost from the Government.
Childhood trauma linked to multiple sclerosis development
Scientist have found that childhood trauma could affect the development and treatment of multiple sclerosis in adulthood.
The EU authorises AstraZeneca COVID vaccine for use
European regulators have approved their third vaccine, AstraZeneca - which comes after a week of tense communications between the two parties.
Three ways to solve the logistical challenges of giving COVID vaccines
An anonymous Doctor explains their ideas for how the NHS could tackle the significant logistical challenges of giving COVID vaccines.
How to embark on becoming a smart digital city of tomorrow
Harjott Atrii, Executive Vice President and Global Head, Digital Foundation Services, at Zensar, explains how cities can embark on a smart/digital journey.
Horizon Europe reveals five main missions for new funding
The new Horizon Europe programme will pick up where Horizon 2020 left off, with five main missions - cancer, climate change, marine environment, smart cities and food security.
Novavax vaccine is 85.6% efficient against UK COVID mutation
Phase Three data from the UK trial shows that Novavax still works powerfully against the UK mutation, with a less intense impact on the South African mutation at 60%.
